Hoppa till innehål
board-image-maarten-de-chateau

Maarten de Château

Board of Directors

Experienced Chief Executive Officer with a demonstrated history of working in the pharmaceuticals industry. Strong entrepreneurship professional skilled in Pharmaceutics, Clinical Research, Life Sciences, Oncology, and Medicine.

Strong academic foundation
MD, PhD with postdoctoral research at Harvard Medical School and academic training at Lund University and Uppsala University, focused on immunology, inflammation and angiogenesis.

Maartens Timeline

  • CEO & Co-founder, Buzzard Pharmaceuticals

  • Founder-led CEO with nearly a decade of hands-on leadership, directly driving company strategy, pipeline development and clinical execution from inception through ongoing clinical studies.

 

  • CEO & Co-founder, Cormorant Pharmaceuticals

  • (acquired by Bristol Myers Squibb)

    Built and led Cormorant Pharmaceuticals to a successful acquisition by Bristol Myers Squibb, demonstrating the ability to create significant value and deliver clinically attractive assets.

 

  • VP Medical Strategy & Innovation, Camurus

  • Responsible for medical strategy and innovation within an established specialty pharma company, bridging clinical development, regulatory strategy and commercial considerations.

 

  • Consultant, Bristol Myers Squibb

  • Provided medical and strategic expertise to a global pharmaceutical organization, gaining first-hand experience of large-scale clinical development and decision-making.

 

  • Medical Program Director, Sobi

  • Led medical and clinical programs within specialty and orphan pharma, with responsibility for cross-functional execution and progression toward regulatory milestones.

 

Bli kontaktad

Fyll i formuläret så kontaktar vi dig så snart vi kan.

Obligatoriskt

Cookiesamtycke

På webbplatsen används nödvändiga kakor för att webbplatsen ska fungera på ett bra sätt. Du kan även välja att samtycka till kakor för statistikinsamling.